Mr. Speaker, how about a trade deal that benefits Canadians? The fact is that the minister just appointed a panel of trade advisers without one single defender of supply management. Three out of ten are actually opposed, and John Manley even called supply management “an obstacle”.
To make matters worse, if Canada agrees to U.S. demands on intellectual property, our prescription drug bills will skyrocket. Can the government assure Canadians that it has not sold out affordable medicine as the cost of joining the TPP?